Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis
Matthew McLoughlin(Wellcome/MRC Cambridge Stem Cell Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Pedro M. Quirós(Universidad de Oviedo), Malgorzata Gozdecka(Wellcome Sanger Institute), George Follows(Addenbrooke's Hospital), Alexander G. Bick(Vanderbilt University Medical Center), Daniel H. Wiseman(University of Manchester), Theodora Foukaneli(Addenbrooke's Hospital), Ludovica Marando(Wellcome/MRC Cambridge Stem Cell Institute), Anna L. Godfrey(University of Namur), Eoin McKinney(University of Cambridge), Alan J. Warren(Wellcome/MRC Cambridge Stem Cell Institute), Josep Nomdedéu(Centre de Recherche Jean Pierre Aubert), Paul Costeas, Aristi Damaskou(Wellcome/MRC Cambridge Stem Cell Institute), Xiaoxuan Liu(University Hospitals Birmingham NHS Foundation Trust), Rachael Wilson(Wellcome/MRC Cambridge Stem Cell Institute), Clea Bárcena(Universidad de Oviedo), Justyna Rak(Wellcome/MRC Cambridge Stem Cell Institute), Yash Pershad(Vanderbilt University Medical Center), Francesco Cucca(University of Sassari), William G. Dunn(Wellcome/MRC Cambridge Stem Cell Institute), E. Joanna Baxter(University of Cambridge), Irina Mohorianu(Wellcome/MRC Cambridge Stem Cell Institute), Margarete A. Fabre(University of Cambridge), Muxin Gu(Wellcome/MRC Cambridge Stem Cell Institute), Valeria Orrù(Institute of Genetic and Biomedical Research), Emma Gudgin(University of Cambridge), Chi Kuen Wong(University of Cambridge), Nicholas Williams(Wellcome Sanger Institute), Ioannis D. Dimitriou, Siddhartha Kar(University of Cambridge), Vasiliki Symeonidou(Wellcome/MRC Cambridge Stem Cell Institute), José Guilherme de Almeida(Universidade do Porto), Jake Tobin(Wellcome/MRC Cambridge Stem Cell Institute), Jyoti Nangalia(Wellcome Sanger Institute), Thomas McKerrell(Wellcome Sanger Institute), Giampiero Valenzano(Wellcome/MRC Cambridge Stem Cell Institute), Sruthi Cheloor Kovilakam(Wellcome/MRC Cambridge Stem Cell Institute), Sean Wen(Wellcome/MRC Cambridge Stem Cell Institute), Edoardo Fiorillo(Institute of Genetic and Biomedical Research), Kevin J. Dawson(Wellcome Sanger Institute), Laura Bond(Wellcome/MRC Cambridge Stem Cell Institute), Jonathan Mitchell(AstraZeneca (Australia)), Daniel Leongamornlert(University of Southern California), Matthew Cullen(Leeds Teaching Hospitals NHS Trust), Moritz Gerstung(European Bioinformatics Institute)
Cited by 22
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
High burden and pervasive positive selection of somatic mutations in normal human skin
|Science|2015|1.8k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k